1.When Dose Losses of Maternal Lymphocytes Response to Trophoblast Antigen or Alloantigen Occur in Women with a History of Recurrent Spontaneous Abortion?.
Korean Journal of Fertility and Sterility 1998;25(2):115-122
The maintenance of a viable pregnancy has long been viewed as an immunological paradox. The deveolping embryo and trophoblast are immunologically foreign to the maternal immune system due to their maternally inherited genes products and tissue-specific differentiation antigens (Hill & Anderson, 1988). Therefore, speculation has arisen that spontaneous abortion may be caused by impaired maternal immune tolerance to the semiallogenic conceptus (Hill, 1990). Loss of recall antigen has been reported in immunosuppressed transplant recipients and is associated with graft survival (Muluk et al., 1991; Schulik et al., 1994). Progesterone (10(-5)M) has immunosuppressive capabilities (Szekeres-Bartho et al., 1985).Previous study showed that fertile women, but not women with unexplained recurrent abortion(URA), lose their immune response to recall antigens when pregnant (Bermas & Hill, 1997). Therefore, we hypothesized that immunosuppressive doses of progesterone may affect proliferative response of lymphocytes to trophoblast antigen and alloantigen. Proliferative responses using 3H-thymidine (3H-TdR) incorporation of peripheral blood mononuclear cells (PBMCs) to the irradiated allogeneic periperal blood mononuclear cells as alloantigen, trophoblast extract and Flu as recall antigen, and PHA as mitogen were serially checked in 9 women who had experienced unexplained recurrent miscarriage, Progesterone vaginal suppositories (100mg b.i.d; Utrogestan, Organon) beginning 3 days after ovulation were given to 9 women with unexplained RSA who had prior evidence of Thl immunity to trophoblast. We checked proliferation responses to conception cycle before and after progesterone supplementation once a week through the first 7 weeks of pregnancy All patients of alloantigen and PHA had a positive proliferation response that occured in the baseline phase. But 4 out of 9 patients (44.4%) of trophoblast antigen and Flu antigen had a positive proliferative response. The suppression of proliferation response to each antigen were started after proliferative phase and during pregnancy cycles. Our data demonstrated that since in vivo progesterone treated PBMCs suppressed more T-lymphocyte activation and 3H-TdR incorporation compare to PBMCs, which are not influenced by progesterone. This data suggested that it might be influenced by immunosuppressive effect of progesterone. In conclusion, progesterone may play an important immunological role in regulating local immune response in the fetal-placental unit. Furthermore, in the 9 women given progesterone during a conception cycle, Only two (22%) repeat pregnancy losses occured in these 9 women despite loss of antigen responsiveness (one chemical pregnancy loss and one loss at 8 weeks of growth which was karyotyped as a Trisomy 4). These finding suggested that pregnancy loss due to fetal aneuploidy is not associated with immunological phenomena.
Abortion, Habitual
;
Abortion, Spontaneous*
;
Aneuploidy
;
Antigens, Differentiation
;
Embryonic Structures
;
Female
;
Fertilization
;
Graft Survival
;
Humans
;
Immune System
;
Immune Tolerance
;
Isoantigens*
;
Lymphocytes*
;
Ovulation
;
Pregnancy
;
Progesterone
;
Suppositories
;
T-Lymphocytes
;
Transplantation
;
Trisomy
;
Trophoblasts*
2.The Effects of Progesterone on Cell Mediated Immunity to Trophoblast in Women with Recurrent Pregnancy Loss.
Korean Journal of Fertility and Sterility 1997;24(3):399-405
Progesterone is necessary for successful pregnancy and had immunosuppressive properties. Peripheral blood mononuclear cells (PBMC) from many women with unexplained recurrent spontaneous abortion responded to trophoblast extract in vitro by prolifertion and releasing soluble, heat-labile factors that are toxic to mouse embryos (embryotoxic factors). Accumulating evidence suggests that T Helper (Th)-1 type immunity to trophoblast is correlated with embryotoxic factor production and is associated with pregnancy loss, while Th2-type immunity is associated with successful gestation. The objective of this study was to determine whether progesterone can inhibit Thl-type cytokine secretion (IFN-gamma, TNF-alpha) by trophoblast-activated peripheral blood mononuclear cells from 23 nonpregnant women (age 25-35) with unexplained recurrent abortion (median 5, range 3 to 15)who otherwise produce embryotoxic factors in response to trophoblast. We also determined whether progesterone affected Th2-type cytokines (IL-4, IL-10) in this system in vitro and if IL-10 (1,500 pg/mL) could inhibit Thl-type immunity to trophoblast. IFN-gamma was detected in 17 of 23 (74%) trophoblast stimulated PBMC culture supernatants (77.94+/-23.79 pg/mL) containing embryotoxic activity. TNF-alpha was detected in 19 (83%) of these same supernatants (703.15+/-131.36 pg/mL). In contrast, none of the supernatants contained detectable levels of IL-4 or IL-10. Progesterone (10-5, 10-7, 10-9M) inhibited Thl-type immunity in a dose dependent manner, but had no effect on Th2-type cytokine secretion. The inhibitory effects of progesterone were abrogated with RU486, but did not affect Th2-type cytokine secretion in trophoblast-activated cell cultures. IL-10, like progesterone also inhibited Thl-type cytokine secretion but had no effect on Th2-type cytokines. These data suggest that therapies designed to suppress Thl-type cytokine secretion in women with recurrent abortion who have evidence of Thl-type immunity to trophoblast may be efficacious in preventing pregnancy loss and should be tested in appropriately designed clinical trials.
Abortion, Habitual
;
Abortion, Spontaneous
;
Animals
;
Cell Culture Techniques
;
Cytokines
;
Embryonic Structures
;
Female
;
Humans
;
Immunity, Cellular*
;
Interleukin-10
;
Interleukin-4
;
Mice
;
Mifepristone
;
Pregnancy*
;
Progesterone*
;
Trophoblasts*
;
Tumor Necrosis Factor-alpha
3.Patient satisfaction in shoulder arthroscopy: telemedicine vs. clinic follow-up visits
Elliot D.K. CHA ; Corey SURACI ; Daniel PETROSKY ; Rebeca WELSH ; Gustin REYNOLDS ; Michael SCHARF ; Joseph BRUTICO ; Gabriella SANTALUCIA ; Joseph CHOI
Clinics in Shoulder and Elbow 2022;25(2):106-111
Background:
The use of telemedicine for postoperative visits is increasing, especially in rural areas. Few studies have investigated its use for arthroscopic shoulder patients. This study aims to evaluate patient satisfaction with telemedicine for postoperative clinic visits following arthroscopic shoulder procedures in a rural setting.
Methods:
Patients were prospectively enrolled using the following exclusion criteria: <18 years, open procedures, and non-compliance follow-up at 6 weeks postoperatively. All patients completed a 13-question satisfaction survey, while telemedicine patients completed an additional, separate seven-question survey. Patients who switched groups completed a four-question prompt to determine the reasons for switching. Differences between groups were evaluated by either Student t-test or Mann-Whitney U-test.
Results:
The study enrolled 32 patients, with five patients following up by telemedicine and 27 in person. Age and distance from clinic were similar between patients who were assigned to the telemedicine group, completed the telemedicine visit, and opted for in-person visits (all p>0.05). Patient satisfaction did not vary significantly based on care by the surgeon, concerns being addressed, thoroughness of visit, overall clinical assessment at a prior visit, and improvements in pain and physical function (all p>0.05). Among patients who opted out of telemedicine visits, the most common reason was a preference to meet in-person but these patients agreed that telemedicine visits are a good idea.
Conclusions
Regardless of type of follow-up, individuals reported similar levels of satisfaction with treatment during the visit and improvements in pain and physical function.
4.Changes of varicella-zoster specific antibody response after live attenuated varicella vaccine(Biken@).
Joseph CHOI ; Byoung Geun LEE ; Pyoung Han HWANG ; Jung Soo KIM
Korean Journal of Infectious Diseases 1992;24(3):209-214
No abstract available.
Antibody Formation*
;
Chickenpox*
5.Prevalence of asymptomatic hematuria, proteinemia and glucosuria in primary school children in Chonju area.
Jin Oh KIM ; Joseph CHOI ; Soo Cheol CHO ; Dae Yeol LEE ; Jung Soo KIM
Journal of the Korean Pediatric Society 1991;34(2):223-229
No abstract available.
Child*
;
Hematuria*
;
Humans
;
Jeollabuk-do*
;
Prevalence*
6.A case of hemiazygos continuation of a left inferior vena cava.
Soo Young CHO ; Joseph CHOI ; Chan Uhng JOO ; Jung Soo KIM
Journal of the Korean Pediatric Society 1991;34(10):1428-1432
No abstract available.
Vena Cava, Inferior*
7.A case of hemiazygos continuation of a left inferior vena cava.
Soo Young CHO ; Joseph CHOI ; Chan Uhng JOO ; Jung Soo KIM
Journal of the Korean Pediatric Society 1991;34(10):1428-1432
No abstract available.
Vena Cava, Inferior*
8.Adoptive transfer of Porphyromonas gingivalis heat shock protein epitope-specific T-cell lines into SCID mice in experimental atherosclerosis.
The Journal of the Korean Academy of Periodontology 2005;35(1):1-8
Bacterial heat shock protein has been one of the components that are responsible to induce autoimmune disease mechanisms in the pathogenesis of atherosclerosis due to high level of homology in sequence with human counterpart. This mechanism may explain how bacterial infectious disease, such as periodontal disease, might contribute to the acceleration of the disease process of atherosclerosis. Porphyromonas gingivalis which is a major periodontal pathogenic bacterial species, has been implicated as one of the pathogenic bacteria playing the role in this context. The present study has been performed to evaluate the anti-atherosclerotic effect of adoptive transfer of Porphyromonas gingivalis heat shock protein epitope-specific T cell lines into severe combined immunodeficiency (SCID) mice. Peptide no. 15 with amino acid sequence VKEVASKTNDspecific T cell line was selected for the transfer. When experimental atherosclerosis was induced in SCID mice adoptively transferred either by the T cell lines (experimental group) or by non-specific mouse T cells (control group), there was no significant difference in the severity and extent of the atherosclerosis induced by hypercholesterol diet.
Acceleration
;
Adoptive Transfer*
;
Amino Acid Sequence
;
Animals
;
Atherosclerosis*
;
Autoimmune Diseases
;
Bacteria
;
Cell Line
;
Communicable Diseases
;
Diet
;
Heat-Shock Proteins*
;
Hot Temperature*
;
Humans
;
Mice
;
Mice, SCID*
;
Periodontal Diseases
;
Periodontitis
;
Porphyromonas gingivalis*
;
Porphyromonas*
;
Severe Combined Immunodeficiency
;
T-Lymphocytes*
9.Is Rectal Indomethacin Sufficient to Prevent Pancreatitis after Endoscopic Retrograde Cholangiopancreatography?.
The Korean Journal of Gastroenterology 2016;67(4):227-229
No abstract available.
10.A Case of Esophageal Candidiasis in a Healthy Child.
Joseph JO ; Sin Ae PARK ; Kyung Dan CHOI
Korean Journal of Pediatric Gastroenterology and Nutrition 2005;8(2):269-274
Esophageal candidiasis is an opportunistic infection, often reported in patients who have acquired immune deficiency syndrome (AIDS), a neoplastic disease, or undergoing protracted antibiotic therapy. Impaired cell mediated immunity was often considered as the major predisposing factor in patients of esophageal mucosal colonization of Candida spp. However, it is increasingly reported that the occurrence of esophageal candidiasis with no underlying disease or immune suppression. We have experienced a case of esophageal candidiasis in a 15-year-old girl who was immunologically normal and have no underlying disease and whose main symptoms were epigastric and retrosternal pain with dysphagia. This case suggests the possibilities of candidal infections in children without predisposing factors such as immune compromised conditions, so it will be needed to differentiate the esophageal candidiasis among healthy children with symptoms of odynophagia and dysphagia.
Acquired Immunodeficiency Syndrome
;
Adolescent
;
Candida
;
Candida albicans
;
Candidiasis*
;
Causality
;
Child*
;
Colon
;
Deglutition Disorders
;
Female
;
Humans
;
Immunity, Cellular
;
Opportunistic Infections